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Abstract
Background: Randomised controlled trials (RCT) can struggle to recruit to target on time. This is especially the case
with hard to reach populations such as those with severe mental ill health. The SCIMITAR+ trial, a trial of a bespoke
smoking cessation intervention for people with severe mental ill health achieved their recruitment ahead of time
and target. This article reports strategies that helped us to achieve this with the aim of aiding others recruiting from
similar populations.
Methods: SCIMITAR+ is a multi-centre pragmatic two-arm parallel-group RCT, which aimed to recruit 400 participants
with severe mental ill health who smoke and would like to cut down or quit. The study recruited primarily in secondary
care through community mental health teams and psychiatrists with a smaller number of participants recruited through
primary care. Recruitment opened in October 2015 and closed in December 2016, by which point 526 participants had
been recruited. We gathered information from recruiting sites on strategies which led to the successful recruitment in
SCIMITAR+ and in this article present our approach to trial management along with the strategies employed by the
recruiting sites.
Results: Alongside having a dedicated trial manager and trial management team, we identified three main themes that
led to successful recruitment. These were: clinicians with a positive attitude to research; researchers and clinicians working
together; and the use of NHS targets. The overriding theme was the importance of relationships between both the
researchers and the recruiting clinicians and the recruiting clinicians and the participants.
Conclusions: This study makes a significant contribution to the limited evidence base of real-world cases of successful
recruitment to RCTs and offers practical guidance to those planning and conducting trials. Building positive relationships
between clinicians, researchers and participants is crucial to successful recruitment.
Keywords: Randomised controlled trial, Recruitment, Severe mental ill health, Smoking cessation, Psychosis, Bipolar
Background
One of the most important challenges faced when
conducting a randomised controlled trial (RCT) is
recruiting the desired number of participants in the
designated time frame [1–3]. An analysis of trials funded
by two large UK agencies indicated that 45% of trials
failed to meet their recruitment target and 46% had to
extend the study duration in order to meet the targets
[4]. Under-recruitment can lead to an underpowered
study and problems estimating the effectiveness of the
intervention or treatment being tested [5]. Some studies
might even be abandoned or closed prematurely. In
cases where studies seek an extension to facilitate
recruitment, there is usually an increase in trial costs
and a delay in obtaining results.
Systematic reviews [6–8] have identified barriers to
recruitment from the perspectives of both recruiters and
participants. Briel et al. [8] identified 28 reasons for
recruitment failure, categorised into four themes:
funding; design; recruiter; and participant. Common
recruitment failure reasons were: overestimation of
eligible participants; recruiter and participant opinions
on trial intervention effectiveness; and burden of trial
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involvement for recruiters and participants. Ross et al.
[9] and Brintnall-Karabelas et al. [7] also found similar
explanations for recruitment failure.
Despite the impact under-recruitment can have on
trials, and evidence highlighting specific barriers to trial
recruitment, there is a lack of information about how
trials that have recruited to time and target have
achieved this. The introduction of the CONSORT state-
ment, to improve reporting of clinical trials [10], has
been recognised as leading to an improvement in the
reporting of RCTs in a psychiatric population [11], but it
does not stipulate the reporting of recruitment strategies,
making sharing of best practice limited. Systematic
reviews [12–14] have identified some trials that evaluated
different recruitment methods, although these were often
small, under-powered or used quasi-randomised or hypo-
thetical designs which limit the generalisability to ‘real-
world’ RCTs.
One systematic review by Belisario et al. [15] investi-
gated methods for recruitment to smoking cessation
studies. High levels of personal contact resulted in better
recruitment rates, although only one study (personalised
phone call vs generic letter) demonstrated a statistically
significant difference (relative risk [RR] = 40.73, 95%
confidence interval [CI] = 2.53–654.74 [16]). Using a
combination of recruitment strategies concurrently, for
example using telephone and text messaging, was
consistently found to increase recruitment rates (RR =
3.38, 95% CI = 1.26–9.08 [17], RR = 29.07, 95% CI =
1.74–485.70 [17]).
The SCIMITAR+ trial follows on from the SCIMITAR
pilot trial with the design of the intervention being
reported elsewhere [18, 19]. The SCIMITAR+ trial
aimed to recruit 400 people with severe mental ill health
[20] (SMI). This population has traditionally been hard
to recruit [21], but SCIMITAR+ met its target recruit-
ment figures ahead of schedule. We therefore report in
this article the strategies and approach to trial manage-
ment used to support recruitment to SCIMITAR+, with
the purpose of extending the evidence base for effective
trial recruitment and aiding others recruiting to trials in
similar populations.
Methods
Full details of the protocol for the SCIMITAR+ study
have been reported elsewhere [20]. Recruitment began
on 1 October 2015 with a stepped increase in the target
number of participants to be recruited per month from
ten in October 2015 to 25 per month by March 2016.
Recruitment was scheduled to end on 31 March 2017;
however, the target recruitment of 400 participants was
reached in mid-October 2016, almost five months ahead
of schedule. The inclusion criteria for the SCIMITAR+
Trial are shown in Table 1.
Participants who wanted to cut down or quit smoking
were randomised to receive either a bespoke smoking
cessation intervention tailored to the needs of people
with SMI or usual care available in their area. Ethical
approval was sought and granted by Leeds East Research
Ethics committee (15/YH/0051). Informed consent was
sought from all participants before recruitment.
Recruitment methods
Five main recruitment strategies were employed. We
recruited via: (1) GP surgeries; (2) community mental
health teams or psychiatrists; (3) service user groups; (4)
poster advertisements; and (5) a lifestyle survey. Irrespect-
ive of the strategy used, participants’ suitability to take part
in the trial had to be established by a clinician.
Results
The SCIMITAR+ trial recruited 526 participants between
October 2015 and December 2016 across 22 sites in
England. Sites recruited varying numbers of participants
as shown in Fig. 1.
We present below the chronological stages of the
research and how we maximised opportunities to recruit
at each stage.
Selecting the research question
The SCIMITAR pilot trial was undertaken in response to a
commissioned call from the National Institute of Health
Research (HTA reference 07/41/05), indicating the import-
ance of the research question in a UK context. In recent
years the need to improve the physical health of those with
mental illness has received national attention in the UK
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Age over 18 years
• Documented diagnosis of SMI
(schizophrenia, delusional/psychotic
illness or bipolar disorder)
• Current smoker (at least 5 per day)
• English speaker
• Pregnant or breastfeeding
• Have drug or alcohol abuse as
a current primary diagnosis
• Lacks mental capacity to consent
Fig. 1 Recruitment by site in the SCIMITAR+ trial
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[22]. Implementation of Commissioning for Quality and
Innovation (CQUIN) targets has seen mental health trusts
respond by improving physical healthcare and working
towards national physical health targets. In addition,
National Institute for Health and Care Excellence guidance
[23] recommended in 2013 that NHS sites become entirely
smoke-free by 2018 and that service users who smoked
should be offered help to quit. This cemented the import-
ance of smoking cessation interventions for people with
mental health problems and led to the perception that the
research question was of importance for both the research
community and healthcare staff.
Designing the recruitment process
SCIMITAR+ was a collaboration between the Mental
Health and Addictions Research Group and York Trials
Unit, both situated in the Department of Health
Sciences at the University of York. This collaboration
combined researchers who specialise in mental health
studies with researchers who specialise in trials. One of
the key factors observed by Farrell et al. [24] in relation
to managing clinical trials effectively was the employment
of a dedicated trial manager. Thus, a dedicated trial man-
ager and trial coordinators with responsibilities for specific
aspects of the trial were employed to ensure the smooth
running of recruitment and allocation to the intervention.
To recruit well from mental health teams, it is important
to establish a close working relationship with clinicians.
Cooperating with clinicians and supporting them to feel
confident and involved with the SCIMITAR+ study was key
in the recruitment strategy for this trial. Identifying and
building a network of professionals with enthusiasm for
research played a crucial role. Multiple methods were used
to support this, including: establishing research champions
within clinical teams; building relationships with individual
professionals in potential recruitment areas; and initiating
conversations between clinicians and researchers about the
trial. Displaying and developing enthusiasm for SCIMITAR
+ and the potential positive outcomes that could be gained
through engagement in the trial was an important part of
these discussions. Such actions fostered good relationships
with clinicians and enabled access to potential participants.
In many sites, researchers were embedded into mental
health teams who focused on engaging that team and
promoting study participation. This ranged from a full-
time commitment through to spending time on wards
and units interacting with staff and patients informally
(achieved with the service support costs – from the local
Comprehensive Research Network [CRN]). Initially, this
allowed the researchers to identify how recruitment
would function best within that team, e.g. where to place
advertisements so that they were most likely to be read.
As the study continued, the presence of the researcher
served as a regular reminder of SCIMITAR+ and meant
that the clinical team had a recognised contact for the
study to whom they could direct questions and any
participant referrals. Informal conversations aided with
networking, and gave the potential for discussions about
SCIMITAR+, to identify team members who were inter-
ested in supporting the research.
A wholehearted approach to recruitment seemed to be
most effective in two areas. First, where the researcher
could speak directly with potential participants, e.g. when
potential participants attended a clinic for a routine long-
acting injection, a motivated clinician actively identifying
potential participants and discussing SCIMITAR+ with
them, particularly where the participant had a trusting
relationship with the clinician, had a positive effect on
recruitment. People recruited in this way appeared more
engaged and genuinely interested in the trial and were
more likely to seek further information. Second, it was
particularly useful when the person promoting the trial
was the Principal Investigator or was in a position to
influence other clinicians to encourage engagement. Most
notably, it was identified that interaction with researchers
could provide both individual clinicians and teams with
evidence that they were meeting their professional respon-
sibilities in relation to research. These include the
responsibilities outlined within the NHS constitution [25],
i.e. supporting access to pertinent research projects, devel-
oping evidence-based practice and enabling patients to
make informed decisions about their care and treatment.
Researchers also supported clinicians with recruitment
during outpatient clinics, such as clozapine and depot
clinics. Initially, study staff would remind the clinicians
of the details and eligibility criteria of the study so that
they felt confident in making referrals. Researchers
would then either sit in the clinic room to speak directly
to patients or wait in a separate room for patients to be
referred to them after their appointment. Primary care
services were also recognised as potential settings for
recruitment and would-be avenues worthy of consider-
ation in future trials as necessary.
Engaging with sites
The trial management team (trial manager and trial
coordinators) worked to ensure that all procedures were
as straightforward as possible, particularly in relation to
study recruitment. The burden on recruiters was mini-
mised by providing recruitment packs containing all the
necessary materials required for recruitment and ensur-
ing that the trial materials were attractive, clear and easy
to understand to both recruitment sites and potential
participants. Frequent meetings were held between the
study’s trial management team and recruiting sites, with
the aim of sharing effective strategies, answering queries
and supporting sites that were experiencing difficulties
with recruitment. The trial management team aimed to
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establish a supportive culture by responding to queries
promptly and taking time to listen to concerns.
The opening of sites was phased with a small number
of sites opening initially so that any problems with
recruitment procedures could be discussed and rectified
early in the process before additional sites joined. This
also allowed a projection of the number of sites needed
to meet the recruitment targets by calculating the number
of participants the early sites were able to recruit in the
first three months.
Several of the mental health trusts involved in SCIMI-
TAR+ had large-scale ‘smoke-free’ programmes ongoing
during the trial. Research staff collaborated with the
smoke-free team, by either inviting them to join the
site’s trial management group or by attending meetings
with physical health nurses and smoking cessation
advisors. Involvement in these meetings enabled SCIMI-
TAR+ researchers to remind staff to discuss the trial
with eligible service users. The weekly staff bulletin was
also used to provide updates on both the smoke-free
campaign and how to refer patients to SCIMITAR+.
Continuing engagement
Team meetings provided useful opportunities to build
relationships with clinicians and ensure continued
engagement with the study. The majority of sites gave pre-
sentations to mental health teams at the beginning of the
study, summarising the key aims, benefits and eligibility
criteria of SCIMITAR+. This ensured that clinical staff
understood the study and how they could help with
recruitment. In many cases, researchers continued to
attend team meetings to give updates and promote
engagement with the study, thus establishing SCIMITAR+
as an important part of the team’s work. Meetings also
provided a forum for addressing the barriers, questions
and concerns identified by clinicians, and were a chance
for researchers to offer practical support.
In addition, researchers used the relationships they had
established with clinicians to work with them on a one-to-
one level. Primarily, this involved screening caseloads for
eligible participants. Researchers could then arrange with
clinicians to attend their next meeting with the potential
participant (with permission) in order to discuss the study
in person. Clinicians reported that they felt more supported
with this approach, as the researcher is better equipped to
speak about the details of the trial and answer any
questions the participant may have. This is particularly use-
ful in services in which several research studies are running
concurrently, as clinicians may find it difficult to talk confi-
dently about each. Speaking with clinicians individually also
allowed researchers to highlight the benefits for clinicians
of assisting with research, e.g. building their professional
development portfolios.
Developing links with local health screening clinics at
an early stage in recruitment was also beneficial. Potential
trial participants were identified by clinic staff and the
option of referral to SCIMITAR+ was discussed during
smoking cessation conversations. The CQUIN targets
further encouraged clinicians to ask every patient whether
they smoked during routine care appointments. This
prompted a conversation about smoking cessation and the
opportunity to participate in SCIMITAR+, thus increasing
recruitment to the trial with minimal impact on the
routine work of the clinicians while maintaining a
mutually supportive relationship with the research team.
We had also hoped that the UK’s Stoptober initiative
would generate increased interest in the trial around this
time, but did not find this. Future trials could consider
how best to take advantage of relevant promotions such
as this.
One particularly successful partnership involved a new
unit dedicated to integrating the physical and mental
healthcare of people with psychosis. The service had a
target to support smokers to quit so the unit was able to
promote SCIMITAR+ to patients which in turn helped the
service to meet their smoking cessation target. Once the
benefits of collaboration with SCIMITAR+ were realised,
the unit’s managers encouraged other managers to raise
awareness of SCIMITAR+ in their departments, thus
expanding the recruitment drive within the NHS trust.
Discussion
This article explores strategies for successful recruitment
in the context of a large, multi-centre RCT (SCIMITAR+).
Three key factors were identified to be important in
increasing recruitment to both SCIMITAR+ and for future
RCTs: clinicians’ attitudes; inter-professional working; and
utilising NHS targets. Within the three themes, building
positive relationships between research and clinical staff
was consistently reported as crucial for effective and
efficient recruitment.
As noted by Patterson et al. [2], patient referral rates to
research studies may be dictated by clinicians’ attitudes to
research and this was observed within the SCIMITAR+
trial. Building relationships between the SCIMITAR+
research team and clinicians helped to increase enthusi-
asm for the study and where this enthusiasm subsequently
transferred from the clinical team to potential partici-
pants, recruitment rate increased, as can be seen in Fig. 1
where sites with greater levels of enthusiasm tended to
recruit better. While recruitment to RCTs can benefit
from targeted involvement of clinicians with an interest in
the study topic, further work through the life course of a
trial is necessary to build and maintain relationships that
sustain interest and enthusiasm among the research staff.
Continuing a presence of research staff within clinical
teams has been found to be crucial in helping to build and
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maintain necessary relationships [26]. Where clinicians
are already invested in the research project, it is prudent
to utilise this presence and enthusiasm to facilitate study
presence and to engage members of the wider clinical
team. Development of these relationships would assist in
enhancing interest and investment in research activity and
may therefore result in increased recruitment activity in
both current and future projects. It is important to note
that the SCIMITAR+ trial is a non-commercial trial
conducted within the NHS. There were therefore no
financial incentives for clinicians to recruit which could
lead to a conflict of interest. In studies where such a
conflict could arise, it would be essential to implement
strategies to mitigate against such conflicts.
The impact of research responsibilities on clinical
teams continues to be a barrier to recruitment, with
many clinicians reporting that clinical workloads mean
they struggle to accommodate research activity [6, 27].
Our research has identified that development and
maintenance of relationships between the research and
clinical teams helps to facilitate support for recruitment
activity (e.g. screening caseloads, addressing queries,
identifying recruitment locations). This corresponds with
previous research in mental health studies, which identi-
fied that establishing good working relationships before
commencing recruitment to studies and then maintain-
ing this over time is important to facilitate successful
study conduct [26].
Where relationships were developed and support
provided during SCIMITAR+, recruitment rates were
comparatively better compared to sites where support
was not so forthcoming. The implication of increased
recruitment rates is that involved NHS sites may
improve performance in relation to predefined NHS
targets, thus increasing future funding levels, which may
increase support available for future research studies.
Future RCTs should therefore consider from the outset
how best to utilise dedicated research staff to support
clinical teams with recruitment activity, to ensure a
targeted approach appropriate to the setting. In addition,
previous research studies exploring barriers and facilita-
tors to study recruitment have identified that relevance
of the study to clinicians and availability of resources to
undertake research activity are critical in facilitating
recruitment in clinical settings [6, 27, 28]. Development
of positive, professional relationships is undoubtedly
likely to help to minimise these barriers and in turn
increase recruitment of participants.
The management of a trial can also have an important
effect on the recruitment rate [29]. In SCIMITAR+, we
had a dedicated trial manager and trial management
team who ensured that trial procedures were as simple
as possible and queries dealt with promptly, both of
which have previously been found to be effective in
aiding recruitment [28]. As recommended by Farrell
[24], a management plan was in place which was
constantly reviewed and revised as the trial progressed.
Alongside this, we aimed to build enthusiasm and a
supportive culture both in the trial management team
and among researchers working on the trial. It is recom-
mended that this approach to trial management is
adopted for future RCTs.
Conclusions
Building positive relationships from the outset of a trial
is crucial to ensure that recruitment is successful. This
study makes a valuable contribution to the limited evi-
dence base of real-world examples of successful
recruitment methods for RCTs and offers practical
guidance to researchers planning and conducting RCTs.
This evidence, and continued sharing of effective
techniques, will help to ensure that all trials have the
best chance of recruiting to time and target.
Future strategies that include electronic recruitment
methods that utilise patient electronic health records
(e.g. Join Dementia Register [JDR]; Consent for Contact
[SLaM C4C]; and Clinical Record Interactive Search
[CRIS]) may also prove useful [30].
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